Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2023 American Society of Cataract and Refractive Surgery Annual Meeting

Glaukos Corporation , an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today... | May 1, 2023

Related Keywords

United States ,San Diego ,California ,American ,Transepithelial Cross ,Ashraf Armia Balamoun ,Williamb Trattler ,Johnp Berdahl ,Interno Canaloplasty ,Miltos Balidis ,Miltiadis Balidis ,Xiongfei Liu ,Philip Dockery ,Kennetha Beckman ,Brendang Cronin ,Ikek Ahmed ,Mitchellc Shultz ,Julia Yu ,Tannerj Ferguson ,Miguel Rechichi ,Markj Gallardo ,Steven Greenstein ,Glaukos Corporation ,Key Corneal Health Presentations ,Key Corneal Health Course ,Key Corneal Health Posters ,American Society Of Cataract ,American Society ,Refractive Surgery ,Glaucoma Presentations ,Year Glaucoma Control ,Second Generation Trabecular Micro Bypass ,Cataract Surgery ,Uncontrolled Glaucoma ,Ab Interno Canaloplasty ,Moderate Open Angle Glaucoma ,Ticiana De Francesco ,Term Endothelial Safety ,Generation Trabecular Micro Bypass ,Open Angle Glaucoma ,Glaucoma Posters ,Trabecular Micro Bypass Stent Implantation ,Cataract Extraction ,Long Term Results ,Blade Goniotomy ,Potentiate Aqueous Outflow ,Reduce Intraocular Pressure ,Combined Phacoemulsification ,South East Asian Eyes ,Combining Two ,Mild To Moderate Glaucoma ,Corneal Health Presentations ,Year Results ,Accelerated Epi O ,Corneal Cross Linking ,Progressive Keratoconus ,Year Follow Up ,Collagen Cross Linking ,Subsequent Topography Altering Surgery ,Corneal Swelling ,Corneal Collagen Cross Linking ,Progressive Keratoconus Patients ,Transepithelial Cross Linking ,Thin Corneas ,Corneal Health Posters ,Topography Guided Epi On Corneal Cross Linking ,Pulsed Irradiation ,Corneal Health Course ,New Cutting Edge Treatments ,Corneal Ectasia ,Micro Invasive Glaucoma Surgery ,Sturge Weber Syndrome ,Glaukos Corporation Stock Exchange ,News ,Information ,Press Release ,Glaukos ,Corporation ,N ,Ophthalmic ,Medical ,Technology ,End ,Harmaceutical ,Company ,Ocused ,Novel ,Therapies ,Or ,The ,Treatment ,F ,Corneal ,Disorders ,Retinal ,Nnounced Gkos Us3773221029 ,